Literature DB >> 15257725

Leptin, but not adiponectin, predicts stroke in males.

S Söderberg1, B Stegmayr, H Stenlund, L-G Sjöström, A Agren, L Johansson, L Weinehall, T Olsson.   

Abstract

OBJECTIVE: To test whether leptin and adiponectin are risk markers for a first-ever stroke. RESEARCH DESIGN, METHODS AND
SUBJECTS: A nested case-referent study identified 276 cases with first-ever stroke (234 cases with ischaemic and 42 with haemorrhagic stroke). Prior to the stroke, they had participated in population-based health surveys in northern Sweden (median time between survey and stroke was 4.9 years). Referents were matched for sex, age, date and type of health survey, and geographical region. Putative risk markers for first-ever stroke, including blood pressure (BP), diabetes, smoking, body mass index (BMI), cholesterol, leptin, and adiponectin, were analysed by conditional logistic regression analysis.
RESULTS: Increased BMI, high cholesterol and fasting glucose levels, diabetes mellitus and hypertension were found in future stroke patients. Whereas leptin levels were higher in male subjects (P = 0.004), adiponectin did not differ between groups. A high leptin level independently predicted stroke in men (OR = 2.46; 95% CI 1.08-5.62) but not in women. Adiponectin levels did not predict stroke. Males with high leptin levels developed stroke faster than males with low leptin levels (P = 0.0009), independently of traditional risk factors.
CONCLUSIONS: Leptin may be an important link to the development of cerebrovascular disease in men, whereas adiponectin does not associate with future stroke.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15257725     DOI: 10.1111/j.1365-2796.2004.01351.x

Source DB:  PubMed          Journal:  J Intern Med        ISSN: 0954-6820            Impact factor:   8.989


  42 in total

1.  High-molecular-weight adiponectin and incident ischemic stroke in postmenopausal women: a Women's Health Initiative Study.

Authors:  Alexandra D Ogorodnikova; Sylvia Wassertheil-Smoller; Peter Mancuso; MaryFran R Sowers; Swapnil N Rajpathak; Matthew A Allison; Alison E Baird; Beatriz Rodriguez; Rachel P Wildman
Journal:  Stroke       Date:  2010-05-27       Impact factor: 7.914

2.  Plasma total and high molecular weight adiponectin levels and risk of coronary heart disease in women.

Authors:  Tobias Pischon; Frank B Hu; Cynthia J Girman; Nader Rifai; JoAnn E Manson; Kathryn M Rexrode; Eric B Rimm
Journal:  Atherosclerosis       Date:  2011-07-20       Impact factor: 5.162

Review 3.  Leptin and cardiovascular disease: response to therapeutic interventions.

Authors:  Kwang Kon Koh; Sang Min Park; Michael J Quon
Journal:  Circulation       Date:  2008-06-24       Impact factor: 29.690

4.  Correlates of leptin in children with chronic kidney disease.

Authors:  Edward Nehus; Susan Furth; Bradley Warady; Mark Mitsnefes
Journal:  J Pediatr       Date:  2014-07-25       Impact factor: 4.406

5.  Are common leptin promoter polymorphisms associated with restenosis after coronary stenting?

Authors:  Julie Anna Bienertová-Vasků; Ota Hlinomaz; Anna Vasků
Journal:  Heart Vessels       Date:  2007-09-20       Impact factor: 2.037

6.  The Västerbotten Intervention Programme: background, design and implications.

Authors:  Margareta Norberg; Stig Wall; Kurt Boman; Lars Weinehall
Journal:  Glob Health Action       Date:  2010-03-22       Impact factor: 2.640

7.  Effect of increased leptin and C-reactive protein levels on mortality: results from the National Health and Nutrition Examination Survey.

Authors:  Stephen M Amrock; Michael Weitzman
Journal:  Atherosclerosis       Date:  2014-06-23       Impact factor: 5.162

Review 8.  Leptin resistance: a possible interface of inflammation and metabolism in obesity-related cardiovascular disease.

Authors:  Seth S Martin; Atif Qasim; Muredach P Reilly
Journal:  J Am Coll Cardiol       Date:  2008-10-07       Impact factor: 24.094

9.  Disruption of protein kinase A in mice enhances healthy aging.

Authors:  Linda C Enns; John F Morton; Piper R Treuting; Mary J Emond; Norman S Wolf; Dao-Fu Dai; G S McKnight; Peter S Rabinovitch; Warren C Ladiges
Journal:  PLoS One       Date:  2009-06-18       Impact factor: 3.240

10.  The role of novel biomarkers of cardiovascular disease in chronic kidney disease: focus on adiponectin and leptin.

Authors:  Omar M Kaisar; David W Johnson; Judith B Prins; Nicole Isbel
Journal:  Curr Cardiol Rev       Date:  2008-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.